Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Marcel Kool

Group leader
-
Phone 088 97 29 000

 

  • Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling

    • dec. 2025
    • Konstantin, Okonechnikov, et al
    • Acta neuropathologica communications
  • Correction

    • dec. 2025
    • Konstantin, Okonechnikov, et al
    • Acta neuropathologica communications
  • High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor

    • sep. 2025
    • Alberto, Delaidelli, et al
    • Neuro-Oncology
  • Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor–ligand interactions

    • jun. 2025
    • Alexander, Beck, et al
    • Nature Cancer
  • Corrigendum to “Implementation of paediatric precision oncology into clinical practice

    • mei 2025
    • Karin P.S., Langenberg, et al
    • European Journal of Cancer
View all publications